Drug Topics - December 12, 2008 - (Page 48) Continuing Education TE ST QU E S TIO NS Write your answers on the form appearing on page 49 (photocopies of the answer form are acceptable) or on a separate sheet of paper. Mark the most appropriate answer. 1. Which ingredient led to the Sulfanilamide Tragedy of 1937? a. Thalidomide b. Propylene glycol c. Diethylene glycol d. Sulfasalazine 2. OBRA ’90 is also known as the: a. Omnibus Bene t Reconciliation Act b. Omnibus Bene t Restoration Act c. Omnibus Budget Reconciliation Act d. Omnibus Budget Restoration Act 3. All of the following are included in the Pharmacist’s Code of Ethics except: a. A pharmacist maintains con dentiality b. A pharmacist should charge a reasonable price, provided the patient is not harmed c. A pharmacist seeks justice in the distribution of health resources d. A pharmacist respects the values and abilities of nurses 4. All of the following are used by the courts in examining what constitutes a pharmacist’s duty except: a. Federal law b. Pharmacist Code of Ethics c. Executive branch rulings d. State Board of Pharmacy regulations 5. Pharmacists have always had the responsibility to do which of the following? a. Counsel patients b. Provide printed information c. Detect drug-drug interactions d. Dispense the correct medication 6. During which decade did the pharmacist’s shield from liability begin to decline as the courts started recognizing a greater responsibility for pharmacists? a. 1970s b. 1980s c. 1990s d. 2000s 7. The standard of care for professionals (pharmacists) includes all the following except: a. Tradition b. Expert opinions c. Federal regulatory agencies d. Court rulings 8. Who enacted OBRA ’90? a. State boards of pharmacy b. State legislatures c. The judicial system d. Congress 9. Regarding patient counseling, what is the primary factor that determines whether matters are deemed “signi cant” in the pharmacist’s opinion? a. Federal law b. State law c. Pharmacist Code of Ethics d. Professional judgment 10. All of the following represent matters that could be deemed signi cant in the pharmacist’s opinion except: a. All probable side effects b. Storage c. Dosage form d. Techniques for self-monitoring drug therapy 11. OBRA ’90 was originally enacted to cover: a. Only Medicare patients b. Only Medicaid patients c. Only Medicare and Medicaid patients d. OBRA ’90 covered all patients 12. Medication therapy management services are covered under Medicare a. Part A b. Part B c. Part C d. Part D 13. Which of the following statements regarding medication therapy management services is false? a. Individualized services may be provided by a pharmacist b. Pharmacists may receive payment for providing services c. Patients with a single disease state are eligible d. Services may be provided by other healthcare providers 14. The following theories are relied upon by courts to support the view that pharmacists do not have a general duty to warn except: a. Contradiction of public policy b. Learned intermediary doctrine c. Interference with the pharmacist-patient relationship d. Drug manufacturers are in the best position to warn the physician of the dangers of prescription drugs 15. In nding that a pharmacist has a duty to warn, all of the following are limited exceptions a court may use, except for: a. The prescription contains a clear error b. The pharmacist has special knowledge of the patient c. The physician delegates the duty to warn to the pharmacist d. The pharmacist voluntarily assumes the duty 16. Which of the following states has held that a duty to warn can exist when there are excessive doses or obvious inadequacies on a prescription? a. Louisiana b. Georgia c. Alabama d. Michigan 17. In Saukas, which 2 medications caused the lawsuit against the pharmacist? a. Depakote and Lamisil b. Depakote and Lamictal c. Theophylline and Cipro oxacin d. Theophylline and Erythromycin 18. The main element courts examine is when determining whether a pharmacist is negligent. a. Board of pharmacy regulation b. Federal law c. Precedent d. Foreseeability 19. All of the following statements are true except: a. All pharmacists will eventually have the duty to warn b. A majority of courts currently holds that a pharmacist has a duty to warn c. There lacks consistency among the states as to what constitutes a pharmacist’s duty to warn d. Providing patients with written information does not shield pharmacists from potential liability 20. Which of the following statements is false? a. Pharmacists should not rely on the “count, pour, lick, and stick” standard b. Pharmacists who advertise that they check for drug interactions will not be held to that standard if they reside in a no-duty-to-warn state c. Counseling patients is a service all pharmacists should provide d. Pharmacists should be aware of the circumstances in which they could be held to have a duty to warn 48 DRUG TOPICS D E C . 15, 2008 W W W.D R U GTO P I C S .C O M http://WWW.DRUGTOPICS.COM
Table of Contents Feed for the Digital Edition of Drug Topics - December 12, 2008 Drug Topics - December 12, 2008 Contents Up Front Up Front In Depth Letters Health-System Edition Cover Story: Controlled Substance Disposal a Growing Problem for Hospitals Pharmacists Hope for Speedy Approvals Deaths from C. Difficile Increasing PharmMD Teams with HealthSpring RX Care Commentary Ohio Hospital Automates Pharmacy The Business Outlook for 2009 OTC The Pharmacist's Duty to Warn: Implications for Pharmacy Practice New Products Viewpoint Drug Topics - December 12, 2008 Drug Topics - December 12, 2008 - Drug Topics - December 12, 2008 (Page Cover1) Drug Topics - December 12, 2008 - Drug Topics - December 12, 2008 (Page Cover2) Drug Topics - December 12, 2008 - Drug Topics - December 12, 2008 (Page 1) Drug Topics - December 12, 2008 - Contents (Page 2) Drug Topics - December 12, 2008 - Contents (Page 3) Drug Topics - December 12, 2008 - Contents (Page 4) Drug Topics - December 12, 2008 - Contents (Page 5) Drug Topics - December 12, 2008 - Contents (Page 6) Drug Topics - December 12, 2008 - Contents (Page 7) Drug Topics - December 12, 2008 - Contents (Page 8) Drug Topics - December 12, 2008 - Contents (Page 9) Drug Topics - December 12, 2008 - Up Front (Page 10) Drug Topics - December 12, 2008 - Up Front (Page 11) Drug Topics - December 12, 2008 - Up Front (Page 12) Drug Topics - December 12, 2008 - Up Front (Page 13) Drug Topics - December 12, 2008 - Up Front In Depth (Page 14) Drug Topics - December 12, 2008 - Up Front In Depth (Page 15) Drug Topics - December 12, 2008 - Letters (Page 16) Drug Topics - December 12, 2008 - Cover Story: Controlled Substance Disposal a Growing Problem for Hospitals (Page H1) Drug Topics - December 12, 2008 - Cover Story: Controlled Substance Disposal a Growing Problem for Hospitals (Page H2) Drug Topics - December 12, 2008 - Cover Story: Controlled Substance Disposal a Growing Problem for Hospitals (Page H3) Drug Topics - December 12, 2008 - Cover Story: Controlled Substance Disposal a Growing Problem for Hospitals (Page H4) Drug Topics - December 12, 2008 - Pharmacists Hope for Speedy Approvals (Page H5) Drug Topics - December 12, 2008 - Deaths from C. Difficile Increasing (Page H6) Drug Topics - December 12, 2008 - Deaths from C. Difficile Increasing (Page H7) Drug Topics - December 12, 2008 - PharmMD Teams with HealthSpring (Page H8) Drug Topics - December 12, 2008 - PharmMD Teams with HealthSpring (Page 17) Drug Topics - December 12, 2008 - RX Care (Page 18) Drug Topics - December 12, 2008 - RX Care (Page 19) Drug Topics - December 12, 2008 - RX Care (Page 20) Drug Topics - December 12, 2008 - RX Care (Page 21) Drug Topics - December 12, 2008 - Commentary (Page 22) Drug Topics - December 12, 2008 - Commentary (Page 23) Drug Topics - December 12, 2008 - Commentary (Page 24) Drug Topics - December 12, 2008 - Ohio Hospital Automates Pharmacy (Page 25) Drug Topics - December 12, 2008 - Ohio Hospital Automates Pharmacy (Page 26) Drug Topics - December 12, 2008 - Ohio Hospital Automates Pharmacy (Page 27) Drug Topics - December 12, 2008 - Ohio Hospital Automates Pharmacy (Page 28) Drug Topics - December 12, 2008 - Ohio Hospital Automates Pharmacy (Page 29) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 30) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 31) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 32) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 33) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 34) Drug Topics - December 12, 2008 - The Business Outlook for 2009 (Page 35) Drug Topics - December 12, 2008 - OTC (Page 36) Drug Topics - December 12, 2008 - OTC (Page 37) Drug Topics - December 12, 2008 - OTC (Page 38) Drug Topics - December 12, 2008 - OTC (Page 39) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 40) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 41) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 42) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 43) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 44) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 45) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 46) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 47) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 48) Drug Topics - December 12, 2008 - The Pharmacist's Duty to Warn: Implications for Pharmacy Practice (Page 49) Drug Topics - December 12, 2008 - New Products (Page 50) Drug Topics - December 12, 2008 - New Products (Page 51) Drug Topics - December 12, 2008 - New Products (Page 52) Drug Topics - December 12, 2008 - New Products (Page 53) Drug Topics - December 12, 2008 - New Products (Page 54) Drug Topics - December 12, 2008 - New Products (Page 55) Drug Topics - December 12, 2008 - Viewpoint (Page 56) Drug Topics - December 12, 2008 - Viewpoint (Page Cover3) Drug Topics - December 12, 2008 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.